Navigation Links
Immucor to Announce Fiscal Fourth Quarter Financial Results on Thursday, July 23, 2009

NORCROSS, Ga., July 9 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it will release its fiscal fourth quarter earnings on Thursday, July 23, 2009 after the market close. The Company will host a conference call on Friday, July 24, 2009 at 8:30 a.m. (Eastern time) to discuss the results.

Investors are invited to participate in this conference call by dialing 1-888-324-9321 (Passcode: BLUD). Investors can also access the call via Webcast through the "About Us - Investor Information" section at A copy of the press release will be available at the same Web address.

For those unable to listen to the live broadcast, a replay of the conference call will be available shortly after its completion and will be archived on Immucor's website for approximately 60 days. Additionally, investors may access a replay of the call for one week beginning at noon on July 24th by dialing 1-866-453-1998 (Passcode: 2583).

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at

SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Immucor Schedules First Quarter Earnings Release and Conference Call
2. Immucor Announces Record Fiscal First Quarter Revenues
3. Immucor, Inc. Appoints New Chief Financial Officer
4. Immucor Announces Update to Second Quarter Conference Call Number
5. Immucor, Inc. Adds Director to Board
6. Immucor Schedules Third Quarter Earnings Release and Conference Call
7. Immucor Announces Record Fiscal Third Quarter Results
8. Immucor Responding to FDA Warning Letter
9. Immucor Schedules Fiscal 2009 Guidance Call
10. Immucor Closes BioArray Acquisition
11. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology: